Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Pharmacokinetics|March 17, 2005
Genetic polymorphisms of UGT1A6 in a Japanese populationMayumi Saeki, Yoshiro Saito, Hideto Jinno, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2009
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Keiko Maekawa, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancerKimie Sai, Mayumi Saeki, Yoshiro Saito, et al.
Drug Metabolism and Pharmacokinetics|April 28, 2005
Genetic variations and haplotypes of UGT1A4 in a Japanese populationMayumi Saeki, Yoshiro Saito, Hideto Jinno, et al.
Drug Metabolism and Pharmacokinetics|October 23, 2004
Genetic variations of the AHR gene encoding aryl hydrocarbon receptor in a Japanese populationHiromi Fukushima-Uesaka, Kimie Sai, Keiko Maekawa, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Naoko Tatewaki, et al.
Drug Metabolism and Pharmacokinetics|May 1, 2008
Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese populationKimie Sai, Yoshiro Saito, Masaya Itoda, et al.
Pageof 7